 |
| Hot MJ stocks issue news VMGI and MJNA |
|
 Hot Stock to Watch
|
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.218
Change (%): + 0.01 (4.81)
Volume: 5,452,604 |
 |
Mile-High Business: HempMeds to Sponsor Cannabis Business Summit in Denver
SAN DIEGO, June 23, 2014 (GLOBE NEWSWIRE) - HempMeds™ proudly announces its participation in and sponsorship of the Cannabis Business Summit hosted by the National Cannabis Industry Association in Denver. The conference takes place on June 24-25 at the Convention Center. The NCIA’s mission is protecting legitimate cannabis businesses, banking access for those businesses, and fair tax policy. There will be a wide variety of presentations from industry leaders; HempMeds is sponsoring a networking session on June 24.
“A major challenge that cannabis-based businesses face is being treated like any other business would,” states Andrew Hard, Director of Public Relations for HempMeds™. “We support the efforts of the NCIA and feel that as the industry evolves, fair taxation and banking regulations must be addressed. There will be an estimated 800 business owners and professionals attending the Cannabis Business Summit. That is a very good indication that the stigma once surrounding cannabis-based businesses is being eliminated, new businesses are sprouting up, and industry growth will dictate the full acceptance of cannabis-based businesses in the U.S.”
Continue Reading
|
 Yesterday's Top Performer
|
Company: Verde Media Group, Inc. (Pink Sheets: VMGI)
|
End of Day:
Price: 0.0059
Change (%): + 0.0017 (40.48)
Volume: 2,403,380 |
|
Verde Media Group Inc. Announces Establishment of R&D Division to Select and Develop Overseas Nursery for High-CBD Cannabis Cultivars
LOS ANGELES, June 23, 2014 (GLOBE NEWSWIRE) - Verde Media Group Inc. (OTC:VMGI) has announced it is in the process of creating a research and development laboratory set-up to determine the optimal strain of commercial cannabis to produce the highest cannabidiol (CBD) content possible. The laboratory will be able to select and optimize the most efficient cultivars for high CBD production and will be capable of clonal expansion for a much larger facility.
The overseas facility complements Verde Biotech Division’s initiative to produce CBD oil for importation and distribution in the United States. The CBD initiative will be a joint venture with Phoenix Energy “PXE” that will co-finance 50% of the project cost. Using proprietary technologies developed by VMBD, highly concentrated CBD oil will be extracted and prepared for importation and distribution to the wholesale market.
Continue Reading |
Other Small Cap News
|
Company: ScripsAmerica, Inc. (OTCBB: SCRC)
|
ScripsAmerica Completes Prepayment of Outstanding Convertible Debt
TYSONS CORNER, VA--(Marketwired - Jun 23, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has completed the prepayment of its outstanding convertible debt.
ScripsAmerica prepaid the remaining balance of an outstanding convertible promissory note issued by Typenex Co-Investment, LLC with a principal amount of 71,432 dollars. The Company prepaid 36,459 dollars due under the one-year note, which includes principal and interest and becomes convertible into shares of ScripsAmerica's common stock at a specified discount on June 21, 2014. The Company's cash payment has rendered its outstanding promissory note paid in full.
Continue Reading
|
Company: Millennium HealthCare Inc. (OTCBB: MHCC)
|
Millennium Healthcare Inc. Advances Patient Care With VasoScan Cardiovascular Assessment Test
GARDEN CITY, N.Y., June 23, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (OTCBB: MHCC) through its wholly owned subsidiary, Millennium Medical Devices, LLC is assisting primary care physicians to offer their patients breakthrough diagnostics that are reimbursable by Medicare and private insurance companies.
At a time when physician practices are challenged by increasing patient needs and falling practice revenues, Millennium Healthcare has positioned itself to provide innovative solutions by offering an advanced early detection diagnostic assessment test for cardiovascular disease, currently the number one cause of death in the United States.
Continue Reading |
Market News
|
By Lee Brodie : CNBC
|
Cramer’s game plan: 9 plays for week ahead
With the Dow Jones industrial average and S&P 500 ending Friday's session at another record high, are you all out of new stock ideas?
Jim Cramer isn't. He works tirelessly, in an attempt to find new ways to leverage the bull. Here's what's on his calendar for the week ahead:
First thing Monday morning Cramer will be looking for insights into the health of the global economy. "The China HSBC manufacturing PMI comes out on Monday," Cramer said, "and it's taken on great significance because U.S. industrial stocks, tethered to China, have been juggernauts. I think the market needs to see some improvement or the industrials may not have the fundamental underpinnings they need as we go into earnings season. A number north of 50 keeps the momentum going in these stocks, but if we get a number south of 49 then I expect a very soggy opening."
Continue Reading
|
By Matthew J. Belvedere: CNBC
|
Fed gives 'green light' for Dow 18K: Siegel
The Federal Reserve's reluctance to hike interest rates any time soon is a signal to investors to keep buying stocks, Wharton Professor Jeremy Siegel told CNBC on Monday.
Siegel is sticking with his prediction of 18,000 for the Dow Jones Industrial Average by the end of the year, as the Dow is just 53 points away from 17,000. The Dow and the S&P 500 closed Friday at record highs again, while the Nasdaq Composite Index climbed to levels not seen in 14 years.
Fed Chair Janet Yellen gave investors the "green light last week," Siegel said in a "Squawk Box" interview at the start of the new trading week. "That's why the so-called defensive sectors have done well, because I'm going to buy yield if there ain't going to be yield anywhere else."
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
